2014
DOI: 10.2350/14-06-1505-oa.1
|View full text |Cite
|
Sign up to set email alerts
|

Age-Dependent Prognostic Effect by Mitosis-Karyorrhexis Index in Neuroblastoma: A Report from the Children's Oncology Group

Abstract: Prognostic effects of Mitosis-Karyorrhexis Index (MKI) used in the International Neuroblastoma Pathology Classification (INPC) are age-dependent. A total of 4,282 neuroblastomas reviewed at the Children’s Oncology Group Neuroblastoma Pathology Reference Laboratory (8/1/2001–3/31/2012) included 2,365 low-MKI (L-MKI), 1,068 intermediate-MKI (I-MKI), and 849 high-MKI (H-MKI) tumors. Cox proportional hazards models were fit to determine age cut-offs at which the relative risk of event/death was maximized in each M… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1

Citation Types

2
24
1
3

Year Published

2015
2015
2019
2019

Publication Types

Select...
5
1

Relationship

4
2

Authors

Journals

citations
Cited by 38 publications
(30 citation statements)
references
References 33 publications
2
24
1
3
Order By: Relevance
“…The presence of bone metastases was recorded at diagnosis based upon all available imaging data, with bone scan required at study entry on both A3961 and A3973 protocols. Biologic factors included MYCN status, ploidy, specific segmental chromosomal aberrations, histologic diagnosis, International Neuroblastoma Pathology Classification category, mitotic karyorrhectic index (MKI), and grade. EFS and overall survival (OS) rates were determined as described in the next section.…”
Section: Methodsmentioning
confidence: 99%
“…The presence of bone metastases was recorded at diagnosis based upon all available imaging data, with bone scan required at study entry on both A3961 and A3973 protocols. Biologic factors included MYCN status, ploidy, specific segmental chromosomal aberrations, histologic diagnosis, International Neuroblastoma Pathology Classification category, mitotic karyorrhectic index (MKI), and grade. EFS and overall survival (OS) rates were determined as described in the next section.…”
Section: Methodsmentioning
confidence: 99%
“…MNA is more common in patients with adrenal primary tumors and less common in those with thoracic primary tumors . There is a strong association between MNA and other tumor biologic and genomic features, such as unfavorable histology, diploidy, high mitotic karyorrhectic index (MKI), and loss of heterozygosity (LOH) at 1p …”
Section: Introductionmentioning
confidence: 99%
“…7 MNA is more common in patients with adrenal primary tumors and less common in those with thoracic primary tumors. 4,7 There is a strong association between MNA and other tumor biologic and genomic features, such as unfavorable histology, 9,10 diploidy, [11][12][13] high mitotic karyorrhectic index (MKI), 14 and loss of heterozygosity (LOH) at 1p. [15][16][17][18][19] MYCN copy number is a discrete variable, but groups have applied cutpoints that define specific tumors as amplified versus nonamplified.…”
Section: Introductionmentioning
confidence: 99%
“…MYCN status is also associated with other adverse prognostic factors. For example, MNA is associated with unfavorable histology, the mitosis‐karyorrhexis index (MKI), and diploid/tetraploid tumors . MNA is associated with the presence of a range of SCAs, especially 1p deletion, though 11q aberration shows a strong inverse relation .…”
Section: Introductionmentioning
confidence: 99%